Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -1.161% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CCn1nc(C)cc1C(=O)N1CCc2c([nH]c3ccccc23)C1c1cc(F)ccc1F
b) COCCNC(=O)c1ccc(CN2CCC(Cc3ccccc3)CC2)cc1
Answer: a. CCn1nc(C)cc1C(=O)N1CCc2c([nH]c3ccccc23)C1c1cc(F)ccc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1nc(C)cc1C(=O)N1CCc2c([nH]c3ccccc23)C1c1cc(F)ccc1F
CCn1nc(C)cc1C(=O)N1CCc2c([nH]c3ccccc23)C1c1cc(F)ccc1F
[1-(2,5-difluorophenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]-(2-ethyl-5-methylpyrazol-3-yl)methanone